hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury

NCT03386708 PHASE1 COMPLETED

The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Healing Poor after Uterus Injury, and exploring the possible mechanisms of umbilical cord mesenchymal stem cell therapy in Healing Poor After Uterus Injury disease

Details

Lead sponsor	Sclnow Biotechnology Co., Ltd.
Phase	PHASE1
Status	COMPLETED
Enrolment	10
Start date	Mon Oct 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Uterus; Injury

Interventions

• intrauterine injection
• human umbilical cord mesenchymal stem cell

Countries

China